LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Code intelligence
0113U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0113U.
Critical code risk
Signal breakdown
4 shown · 4 total in platform
Risk: Critical
1
Critical
25%
3
High
75%
0
Routine
0%
0
Low
0%
New this month
+1
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
Proposed LCD DL40429: MolDX: Transcriptional Biomarkers for Therapeutic Decision-Making in Renal Carcinoma — Palmetto GBA
Policy LCD-DL40429 · Oncology
Proposed LCD: Molecular biomarkers for renal carcinoma tx decisions—comment by 1
LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
Audit documentation
Building an audit file that includes 0113U?
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription